Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

By J. Hu, H.-P. Sun, C. Niu, H. Yan, T. Yu, Guo-Qiang Chen, Z.-X. Shen, Sj Chen, Zhen-yi Wang, Zhu Chen. 2001

942 citations recorded by the source corpus.

Subfields: Biochemistry, Hematology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/c3584f5879234c09a0a81d2938f7949365b33e15

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. J. Cortes
2. H. Kantarjian

Citations in the corpus

• Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia (2003, background): “Soignet et al.(9) reported a CR rate of 92% among 12 patients who had a median CR duration of 5 months.”